Kura Oncology, Inc. (KURA)

Kura Oncology Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Kura Oncology stock have an average target of 25.5, with a low estimate of 10 and a high estimate of 40. The average target predicts an increase of 288.42% from the current stock price of 6.57.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$25.5	$28	$40
Change	+52.32%	+288.42%	+326.50%	+509.29%

Analyst Ratings

The average analyst rating for Kura Oncology stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	3	6	6	6	5	5
Buy	3	3	3	3	3	3
Hold	1	1	1	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	10	10	11	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Dai UBS	UBS	Strong Buy Maintains $27 → $14	Strong Buy	Maintains	$27 → $14	+113.25%	Mar 6, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+509.29%	Feb 27, 2025
Reni Benjamin JMP Securities	JMP Securities	Buy Reiterates $28	Buy	Reiterates	$28	+326.50%	Feb 6, 2025
Robert Driscoll Wedbush	Wedbush	Buy Maintains $34 → $36	Buy	Maintains	$34 → $36	+448.36%	Feb 6, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $37 → $40	Strong Buy	Maintains	$37 → $40	+509.29%	Feb 6, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

60.97M

Increased by 13.15%

from 53.88M

Revenue Next Year

196.23M

Increased by 221.86%

from 60.97M

EPS This Year

-2.22

from -2.02

EPS Next Year

-2.05

from -2.22

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	53.88M	60.97M	196.23M	302.88M
Revenue Growth	-	-	-	-	-	13.15%	221.86%	54.35%
EPS	-1.69	-1.97	-2.03	-2.08	-2.02	-2.22	-2.05	-1.83
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	16	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	200.5M	473.8M	1.2B
Avg	61.0M	196.2M	302.9M
Low	n/a	7.6M	55.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	272.2%	677.1%	525.3%
Avg	13.1%	221.9%	54.3%
Low	-	-87.5%	-71.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.00	-0.48	3.19
Avg	-2.22	-2.05	-1.83
Low	-3.23	-4.69	-4.00

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.